SCHEMBL9938847

SCHEMBL9938847

CCOC(=O)C(O)CC(Cc1ccc(-c2ccccc2)cc1)NC(=O)c1cc(C(=O)NCCC(C)C)n[nH]1

nearest known ligand 0.66

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 20/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9929943 1.00 MME (0.66) MME
SCHEMBL9930204 0.91 MME (0.79) MME
SCHEMBL9930030 0.91 MME (0.79) MME
SCHEMBL9930169 0.90 MME (0.65) MME
SCHEMBL9930049 0.90 MME (0.65) MME
SCHEMBL9929525 0.90 MME (0.65) MME
SCHEMBL9929725 0.87 MME (0.78) MME
SCHEMBL18724675 0.87 MME (0.78) MME
SCHEMBL9930014 0.87 MME (0.80) MME
SCHEMBL9930013 0.87 MME (0.80) MME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651896-A1 NEPRILYSIN INHIBITORS Theravance, Inc. (US) 2013-10-23 — — EP disclosed
WO-2012082853-A1 NEPRILYSIN INHIBITORS THERAVANCE, INC. (US) 2012-06-21 — — WO disclosed
Send feedback